we pave the way for biotechs

Campus Berlin-Buch GmbH

Campus Berlin-Buch GmbH develops and operates Campus Berlin-Buch, the leading location for biotechnology and biomedicine in the health region of Berlin. The BiotechPark Berlin-Buch is the most important division of the company, which was founded in 1995, and is an integral part of the campus.

The main tasks of Campus Berlin-Buch GmbH are to aid biotechs – from start-ups to mature enterprises – in settling on campus and to provide them with assistance and support. An experienced and dedicated team is poised to provide flexible and individual services and solutions.

Sitz der Campus Berlin-Buch GmbH - Haus D85

On behalf of the campus community, Campus Berlin-Buch GmbH operates a state-of-the-art, secure and efficient communication and information system with services and support, ensures comprehensive facility management and organizes and coordinates the technical operation of the campus infrastructure and maintenance of the green areas. The highly popular Life Science Learning Lab, which has a reputation throughout Germany as a life science education institution, promotes young talent, offers professional qualification courses as well as courses and activities for the general public.

Furthermore, Campus Berlin-Buch GmbH coordinates activities that affect the whole district of Buch. Within the framework of the Pankow District Alliance for Economic Affairs and Labor (BBWA), Campus Berlin-Buch GmbH is implementing the project “Development of the health region Berlin-Buch as an integral location for knowledge-based healthcare industry". The aim of this project, which started in 2011 and is scheduled to run through 2014, is to optimize the framework conditions of the health region Berlin-Buch and to develop it into a leading science, industry and health cluster within Berlin, underscoring the city’s focus on health. A further goal is to increase the attractiveness of the location for other companies.

As an economically independent, non-profit company with a public mandate, Campus Berlin-Buch GmbH is a neutral and intermediary partner. It uses the interfaces to research, clinical research, companies, administration, policy makers and the general public and participates in competence networks and support and service networks at regional and international levels.

The shareholders of Campus Berlin-Buch GmbH are the Land of Berlin (50.1 %), the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) (29.9 %) and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) (20 %).